ASXL1 and cancer: Importantly, a cancer-associated mutation of BAP1 in its CTD, BAP1ΔR666-H669, that abrogates its interaction with ASXL1 and ASXL233, also failed in promoting DEUBAD monoubiquitination (Fig. 2a, b).